|  Help  |  About  |  Contact Us

Publication : Cutting Edge: l-Arginine Transfer from Antigen-Presenting Cells Sustains CD4(+) T Cell Viability and Proliferation.

First Author  Crowther RR Year  2022
Journal  J Immunol Volume  208
Issue  4 Pages  793-798
PubMed ID  35101895 Mgi Jnum  J:336971
Mgi Id  MGI:7257960 Doi  10.4049/jimmunol.2100652
Citation  Crowther RR, et al. (2022) Cutting Edge: l-Arginine Transfer from Antigen-Presenting Cells Sustains CD4(+) T Cell Viability and Proliferation. J Immunol 208(4):793-798
abstractText  Metabolomics analyses suggest changes in amino acid abundance, particularly l-arginine (L-ARG), occur in patients with tuberculosis. Immune cells require L-ARG to fuel effector functions following infection. We have previously described an L-ARG synthesis pathway in immune cells; however, its role in APCs has yet to be uncovered. Using a coculture system with mycobacterial-specific CD4(+) T cells, we show APC L-ARG synthesis supported T cell viability and proliferation, and activated T cells contained APC-derived L-ARG. We hypothesize that APCs supply L-ARG to support T cell activation under nutrient-limiting conditions. This work expands the current model of APC-T cell interactions and provides insight into the effects of nutrient availability in immune cells.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

Trail: Publication

0 Expression